Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Starpharma: Human Trials of Anti-HIV Product

July 31st, 2003

Starpharma: Human Trials of Anti-HIV Product

Abstract:
Melbourne biotech company Starpharma Pooled Development Ltd has received FDA clearance to proceed with human clinical trials of its new dendrimer nano-drug VivaGel. The gel will be used as a preventative against the transmission of HIV during sexual intercourse. It has been highly successful in preventing infection in monkey trials using a humanised strain of simian immunodeficiency virus.

Source:
Starpharma

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Spinning strands hint at folding dynamics: Rice University lab uses magnetic beads to model microscopic proteins, polymers October 17th, 2017

Arrowhead Pharmaceuticals to Present Preclinical Data on ARO-AAT at The Liver Meeting(R) October 10th, 2017

Arrowhead to Present at Chardan Gene Therapy Conference October 3rd, 2017

'CRISPR-Gold' fixes Duchenne muscular dystrophy mutation in mice October 3rd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project